SLC25A17 and metastatic malignant neoplasm in the lymph nodes: It shows that different SLC25A17 expression, age, and lymph node metastasis have a corresponding score, and the total score they add up corresponds to the 1-, 3-, and 5-year survival rates of HNSCC patients below.